IGF-1 and IGFBP3 as indirect markers of hepatic insulin resistance and their relation to metabolic syndrome parameters in liver steatosis patients
Objective. The aim of the present study was to assess insulin-like growth factor 1 (IGF-1) and IGF-binding protein 3 (IGFBP3) as markers of insulin resistance in patients with prediabetes and type 2 diabetes mellitus (TDM2).
Main Authors: | Fraenkel Emil, Lazurova Ivica |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2023-01-01
|
Series: | Endocrine Regulations |
Subjects: | |
Online Access: | https://doi.org/10.2478/enr-2023-0009 |
Similar Items
-
Editorial: The Role of the IGF/Insulin-IGFBP Axis in Normal Physiology and Disease
by: Shin-Ichiro Takahashi, et al.
Published: (2022-04-01) -
Insulin-like Growth Factors (IGFs) and their binding proteins (IGFBPs) as biomarkers of catabolism
by: Nedić Olgica, et al.
Published: (2007-01-01) -
Expression of genes encoding IGF1, IGF2, and IGFBPs in blood of obese adolescents with insulin resistance
by: Minchenko Dmytro O., et al.
Published: (2019-01-01) -
The IGF/Insulin-IGFBP Axis in Corneal Development, Wound Healing, and Disease
by: Whitney L. Stuard, et al.
Published: (2020-03-01) -
Effects of Insufficient Levels of Dietary Protein on IGF-I and IGFBPs in Young Chickens
by: Kenji Nagao, et al.
Published: (2010-07-01)